Vitamin K [EPC]

6600 reported adverse events

Drugs of this class: PHYTONADIONE ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN-5 PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, FOLIC ACID, BIOTIN, CYANOCOBALAMIN ARNICA MONTANA, CALENDULA OFFICINALIS, CARDUUS MARIANUS, GRAPHITES, HYPERICUM PERFORATUM, STAPHYSAGRIA, THIOSINAMINUM, VITAMIN K1 ASCORBIC ACID, VITAMIN A PALMITATE, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5-PHOSPHATE SODIUM, PYRIDOXINE HYDROCHLORIDE, NIACINAMIDE, DEXPANTHENOL, ALPHA-TOCOPHEROL ACETATE, VITAMIN K1, FOLIC ACID, BIOTIN, CYANOCOBALAMIN VITAMIN K1 - PHYTONADIONE VITAMIN K1, PHYTONADIONE

These side effects are most commonly reported by patients taking drugs of the Vitamin K [EPC] class:

#	Side effect	Count
0	NAUSEA	447
1	OFF LABEL USE	380
2	FATIGUE	370
3	VOMITING	361
4	DYSPNOEA	330
5	DIARRHOEA	328
6	SEPSIS	292
7	ABDOMINAL PAIN	277
8	PYREXIA	265
9	CONSTIPATION	253

See all common reactions for Vitamin K [EPC]

Drugs of the Vitamin K [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	APPENDICOLITH	119	0.7628
1	HAEMORRHAGE NEONATAL	6	0.1333
2	HYPER IGE SYNDROME	11	0.1236
3	CYSTIC FIBROSIS RELATED DIABETES	7	0.0787
4	FACTOR V INHIBITION	10	0.0571
5	VITAMIN K DEFICIENCY	15	0.0514
6	RENAL VASCULAR THROMBOSIS	6	0.0484
7	TERMINAL ILEITIS	8	0.0476
8	INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS	218	0.0464
9	DISTAL INTESTINAL OBSTRUCTION SYNDROME	10	0.0452

See all enriched reactions for Vitamin K [EPC]